We aimed to histopathologically and biochemically investigate the protective effects of silymarin (SLY) against cardiac injury induced by a high-dose isotretinoin (ISR) administration.
Introduction
Isotretinoin (ISR), which is also known as 13-cis-retinoic acid, is a vitamin A derivative that suppresses the proliferation of sebaceous glands, keratinization of hair follicles, and the activity of inflammatory cytokines (1) (2) (3) (4) . This substance is widely used in the treatment of acne vulgaris at present. However, its long-term use often causes disorders in the liver and kidney tissues. In addition to its toxic effects, it is a powerful teratogenic agent (5) . It has also been shown to cause depression by lowering orbitofrontal cortex activity in patients (3) .
Retinoic acid, synthesized from the epicardium during embryonic development, is required for the development of cardiac myocytes (6) . Secretion of retinoic acid that is less or more than normal has been demonstrated to cause abnormal heart development and heart defects during this period (7) . However, no studies showing that high-dose retinoic acid intake creates a pathological or toxic effect on heart tissue have been encountered.
Silymarin (SLY) is among the flavonolignans that are condensed in the seed extracts of the Silybum marianum plant (8) . SLY, which is a powerful antioxidant, has been shown to inhibit lipid peroxidation and prevent oxidative damage by increasing the levels or activity of antioxidant enzymes, especially glutathione (GSH) (9) (10) (11) (12) (13) . It has been reported that SLY, which was shown in various studies to have protective effects, especially on the heart, kidney, and the organs of the nervous system, reduces the activity of carcinogens and regulates immunological functions (14, 15) .
In this study, we aimed to determine the histopathological and biochemical changes that high-dose ISR applied to BALB/c mice would create in the heart tissue, and to determine the possible antioxidative effects of SLY on these changes. To the best of our knowledge, this is the first study conducted on this subject.
Methods

Experimental plan
In our study, 32 BALB/c young (3 months) male mice were used. During the 6-week experiment, all mice were fed with normal pelleted feed and tap water. Randomly selected mice were divided into control, ISR, SLY, and ISR+SLY groups, with 8 mice in each. ISR was bought from the Alfa Aesar (J61666, Massachusetts, USA) company and SLY (S0292) from Sigma-Aldrich, (Germany).
Dimethyl sulfoxide (DMSO)+physiological saline solution ((PSS), which is the solvent for ISR and SLY) was applied to the control groups at a ratio of 1:1 during the experiment. ISR was dissolved in 0.1 mL of DMSO+PSS and was given at a dose of 40 mg/kg/day for 6 weeks through oral gavage, and SLY was dissolved in 0.2 mL of DMS+PSS and was given at a dose of 200 mg/kg/day in the same way. In order to determine the possible therapeutic effect of silymarin, ISR was initially administered to the ISR+SLY group, and after 4 hours, SLY was administered at the indicated doses. At the end of the experiment, cardiac blood samples were taken for biochemical analysis under anesthesia administered intraperitoneally with 5 mg/kg xylazine and 80 mg/kg ketamine. Following this procedure, the hearts were removed and procedures were started for histopathological evaluation.
The study methods were approved by decision No. 2013-237 of the Experimental Animals Local Ethics Committee of the Bezmiâlem Foundation University.
Histological procedures
The removed cardiac tissues were divided in two and fixed in 10% neutral buffered formaldehyde for 1 week. Then, they were dehydrated by being passed through an alcohol series whose densities progressively increased. Sections that were 4-μm thick were taken from blocks obtained by paraffin embedding and stained with hematoxylin-eosin and Masson trichrome. Samples were examined with a light microscope (Nikon Eclipse i5 light microscope; Nikon Instruments Inc., Tokyo, Japan) and the changes were scored (Nikon NIS Elements version 4.0 imaging analysis system; Nikon Instruments Inc., Tokyo, Japan).
Scoring was histopathologically performed considering necrosis, bleeding, and intercellular edema. Evaluation was made for each datum as 0: No change; 1: slight change; 2: moderate change; 3: severe change. The total maximum mean histopathological score (MHS) values for each sample were evaluated as 9.
The TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP-X nick end labeling assay, Roche-11 684 795 910-kit) fluorescence staining technique was used to identify apoptotic cells. The staining method was carried out as specified by the manufacturer. The number of apoptotic cells was obtained by counting the TUNEL-positive cells and calculating the group averages in 20 sites randomly selected at 20× magnification in each section under a fluorescence microscope.
Biochemical procedures
Sample collection and preparation
Blood samples were collected by cardiac puncture into heparinized tubes. After removing the plasma parts of samples by centrifuging at 1,500 x g for 10 minutes, the remaining erythrocyte suspension was washed three times with 0.9% cold sodium chloride (NaCl) at equal volumes. Samples were stored at -20°C until the parameters were analyzed.
Measurement of hemoglobin (Hb)
The erythrocyte concentration in the hemolysates was spectrophotometrically measured using the cyanmethemoglobin method (16) . Blood samples were mixed with 5 ml Drabkin's solution (1% sodium bicarbonate, 0.005% potassium cyanide, and 0.02% potassium ferricyanide) for determining Hb concentrations. An Hb standard was obtained from Sigma (St. Louis, MO, USA).
Antioxidant enzyme measurements
Superoxide dismutase (SOD) activity in erythrocyte hemolysates was measured by the reduction inhibition rate of 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl tetrazolium chloride (INT) (Ransod SD 125, Randox Lab.) and Hb was specified as U/g. GSH peroxidase (GSH-Px) activity in full blood was measured using the modified method described by Paglia and Valentine (17) . GSH-Px catalyzes the GSH oxidation with hydroperoxide clusters. In the presence of GSH reductase and NADPH, oxidative GSH (GSHG) is rapidly converted to a reduced form, resulting from the oxidation of NADPH to NADP. The decrease in absorbance was measured at a wavelength of 340 nm (Ransel RS 505, Randox Lab.). The activity of GSH reductase was measured spectrophotometrically at a wavelength of 340 nm (18) . GSH peroxidase catalyzes the oxidation of GSH to GSSG by means of hydrogen peroxide. The conversion rate of GSSG is measured by the GSH re-ductase reaction (19) . GSH transferase (GST) activity was assessed using the method specified by Habig et al. (20) . The reduced GSH level in erythrocyte hemolysates was determined by Beutler's method (21) . Catalase (CAT) was spectrophotometrically measured at 230 nm by a procedure based on the measurement of the oxygen volume that occurs as a result of the dissociation of hydrogen peroxide. SOD, CAT, and GSH-Px activities were expressed as Hb U/g. All antioxidant enzyme activities were measured on a multi-plate reader (Varioskan Flash Multimode Reader, Thermo, USA).
Lipid peroxidation
Lipid peroxidation was measured in red blood cells by using the method stated by Stocks et al. (22) , and in plasma samples by using the method stated by Ohkawa et al. (23) . Other aldehydes were calculated by monitoring the pink color resulting from the reaction between MDA and thiobarbituric acid.
Statistical analysis
For comparing histopathological changes and the number of apoptotic cells among the groups, a t-test was used. The significance level was considered as p≤0.05. All statistical analyses were performed by using Statistical Package for the Social Sciences 18.00 (SPSS, IBM Corp., New York, USA) software. Bar graphs were prepared through GraphPad Prism Version 6.01 (USA) software.
Results
Biochemical analyses
The levels of GSH (p=0.013), GSH-Red (p=0.002), and GST (p=0.002), and the activities of GSH-Px (p=0.002), CAT (p=0.002), and SOD (p=0.003) in the group of isotretinoin were seen to be quite low compared to the control group. The highest antioxidant enzyme levels were detected in the SLY group. After the application of ISR, SLY application was determined to have significantly increased the antioxidant enzyme level [GSH (p=0.018), GSH-Px (p=0.002), GSH-Red (p=0.002), GST (p=0.002), CAT (p=0.015), SOD (p>0.05)].
The mean E-MDA (p=0.004) and P-MDA (p=0.004) values for the isotretinoin group were higher than for the control group. It was observed that SLY application significantly reduced E-MDA (p=0.003) and P-MDA (p=0.005) values and, consequently, the lipid peroxidation.
All biochemical results are shown in Table 1 and in Figures  1 and 2 .
Histopathological analyses
In the control group, it was seen that all the layers of the heart were of normal histological appearance, and that the heart muscle cells preserved their normal cellular properties. No pathological findings were discovered in this group (Figure  3a, b) . In the SLY group, all the layers were also of normal appearance in general. The microscopic characteristics of the heart muscle cells were the same as in the control group (Figure 4) . A very small amount of bleeding was observed between the muscle fibers only in one mouse.
Necrosis, hemorrhage, and intercellular edema were quite apparent in the heart tissues of the isotretinoin groups. The muscle fibers were observed to be quite distant from each other because of severe edema and hemorrhage (Figure 5a, b, 6 ). It was observed with the hematoxylin-eosin staining method that the cytoplasm of the necrotic cells was darker and more acidophilic than that of the healthy heart cells, and the nuclei were pyknotic or stained pale ( Figure 6 ). In addition, conges-tion was encountered sporadically, though not common in the sections (Figure 7) . The MHS of this group was higher than that of the control group (p=0.001). In the ISR+SLY group, which was designed as a treatment group, it was observed that the findings obtained were not different from the ISR group; similar to this group, the areas of hemorrhage and necrosis covered a large area and the muscle fibers were separated from each other (Figure 8 ). The mean histopathological scores were found to be almost the same in both groups ( Table 2) . Although there were no dif-ferences in the ISR and ISR+SLY groups in terms of general scoring results, a statistically significant difference was found between the two groups in terms of necrosis density (p≤0.001) ( Table 3 ).
The mean number of apoptotic cells determined by the TUNEL method was 14.25±6.36 in the control group, 13.00±5.37 in the SLY group, 57.88±38.26 in the ISR group, and 20.75±7.15 in the ISR+SLY group (Table 4 ). It was observed that ISR induced apoptosis and SLY suppressed apoptosis alone or after ISR application (p=0.017) (Figure 9, 10 ).
Discussion
It was shown that ISR induced cardiac remodeling (24) in rats in which ISR was applied at normal physiological doses (0.5 mg/kg) and prevented fibrosis and hypertrophy of the heart in patients who received acne vulgaris treatment (25) . It was observed in our study that long-term administration of high-dose ISR caused severe necrosis, interstitial edema, congestion, and bleeding in the heart. As a matter of fact, the MHS, e-MDA, and p-MDA values of this group were higher than for the control group (p=0.001, p=0.004, and p=0.004, respectively). MDA is the end product of lipid peroxidation and is one of the most important indicators of the cell membrane integrity, and thus cell damage. Indeed, we have shown that ISR administration also causes apoptotic and necrotic cell death in the liver and kidney tissues (unpublished finding). On the other hand, in our study, significant decreases in antioxidant enzyme levels or activities in the ISR group indicate that ISR suppresses cellular antioxidant enzyme systems. We believe that ISR causes oxidative stress in cells.
It has been shown that silymarin inhibits the entry of toxic agents into cells by increasing cell membrane resistance. In our study, it was important that SLY was given approximately simultaneously with ISR in order to prevent toxic effects. In many studies, SLY has been shown to prevent lipid peroxidation and to have antioxidant effects by increasing GSH levels and CAT enzyme activities (9) (10) (11) (12) (13) 15) . As in previous studies, we found that SLY increased antioxidant enzyme levels and prevented lipid peroxidation. As a matter of fact, all antioxidant levels of the ISR+SLY group were significantly higher than in the ISR group. Conversely, necrosis rates, e-MDA, and p-MDA levels were significantly lower (p≤0.001, p=0.003, and p=0.005, respectively). Moreover, the rate of apoptosis, which was quite high in the ISR group, was observed to decrease significantly with SLY administration (p=0.017). SLY has been shown to protect cells against DNA damage, with antiapoptotic properties in addition to antioxidant effects (26) . These data demonstrate that SLY suppresses cellular damage by supporting the antioxidant enzyme system. It was reported in a similar study that SLY showed a protective effect against doxorubicin-induced mild cardiac damage (15) . One notable result of our study was that SLY did not suppress intercellular edema, congestion, and bleeding. No study suggesting that SLY is effective against edema, bleeding, and congestion has been encountered so far. The prevention of cellular damage is a very promising finding for the treatment of various conditions where cardiac tissue with poor regeneration power becomes damaged. However, in order to make the results more meaningful, it could be suggested that the study should be renewed by making lipid peroxidation and antioxidant agent measurements of the heart tissue.
Conclusion
In the result of the evaluations; it was observed that silymarin increased the activities of antioxidant enzymes, primarily plasma GSH enzyme levels, and reduced lipid peroxidation by lowering the E-MDA and P-MDA levels, against heart tissue damage caused by high-dose isotretinoin. In addition, it was specified to have apoptosis-lowering effect by partially suppressing apoptotic cell death caused by isotretinoin. As a result, it was concluded that silymarin has an antioxidant and antiapoptotic effect on heart tissue. Ethics Committee Approval: Ethics committee approval was received for this study from Bezmiâlem Vakıf University Ethics Committee of Experimantal Animal. 
